BeOne Medicines (ONC) Total Liabilities (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Total Liabilities data on file, last reported at $3.8 billion in Q1 2026.

• On a quarterly basis, Total Liabilities rose 61.96% year-over-year to $3.8 billion in Q1 2026; TTM through Mar 2026 was $3.8 billion, a 61.96% increase from a year earlier, with the FY2025 full-year figure at $3.8 billion, up 47.85% from the prior year.
• Total Liabilities for Q1 2026 stood at $3.8 billion, down from $3.8 billion in the prior quarter.
• Over the last five years, Total Liabilities for ONC reached as high as $3.8 billion in Q4 2025 and fell as low as $1.1 billion in Q4 2022.
• Historically, Total Liabilities has averaged $2.4 billion across 5 years, with a median of $2.3 billion in 2024.
• Across the five-year window, Total Liabilities plunged 54.31% in 2022 and soared 106.59% in 2023, its largest moves.
• Year by year, Total Liabilities stood at $1.1 billion in 2022, then soared by 106.59% to $2.3 billion in 2023, then advanced by 14.14% to $2.6 billion in 2024, then surged by 47.85% to $3.8 billion in 2025, then fell by 0.89% to $3.8 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $3.8 billion in Q1 2026, $3.8 billion in Q4 2025, and $3.5 billion in Q3 2025.